Clinical Trial Update: Doxycycline, Temozolomide and Ipilimumab in Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating doxycycline with temozolomide and ipilimumab in melanoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Doxycycline (Doxycycline)
• Temozolomide (Temozolomide)
• ipilimumab (ipilimumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-09-02